Please wait a minute...
Journal of ZheJiang University(Medical Science)  2017, Vol. 46 Issue (3): 315-320    DOI: 10.3785/j.issn.1008-9292.2017.06.15
    
Research progress on the relationship of brown adipose tissue with polycystic ovary syndrome
FU Xiaohua, XU Weihai, QIU Shengchun, SHU Jing
Department of Reproductive Endocrinology, People's Hospital of Zhejiang Province, Hangzhou 310014, China
Download:   PDF(975KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

Brown adipose tissue (BAT) holds great promise for the prevention and treatment of metabolism diseases through thermoregulation. Polycystic ovary syndrome (PCOS) is a complex condition with anovulation, hyperandrogenism, and polycystic ovaries, and also manifests glucolipid metabolic disorders. Recent researches have shown that transplantation of BAT into a PCOS rat could significantly alleviate the phenotypes. This article reviews the role of BAT in pathogenesis of PCOS, which may provide information for prevention and treatment of PCOS.



Key wordsAdipose tissue, brown      Polycystic ovary syndrome      Metabolism      Review     
Received: 21 November 2016      Published: 25 June 2017
CLC:  R589  
  R711.75  
Cite this article:

FU Xiaohua, XU Weihai, QIU Shengchun, SHU Jing. Research progress on the relationship of brown adipose tissue with polycystic ovary syndrome. Journal of ZheJiang University(Medical Science), 2017, 46(3): 315-320.

URL:

http://www.zjujournals.com/xueshu/med/10.3785/j.issn.1008-9292.2017.06.15     OR     http://www.zjujournals.com/xueshu/med/Y2017/V46/I3/315


棕色脂肪组织及其与多囊卵巢综合征关系的研究进展

棕色脂肪组织通过线粒体的脂质氧化解偶联产热参与人体的能量平衡,预测可成为预防和治疗代谢相关疾病的新靶点。多囊卵巢综合征(PCOS)患者除伴有生殖功能障碍外还普遍存在糖脂代谢异常,动物模型研究提示移植棕色脂肪组织可改善其临床表型。通过研究棕色脂肪在PCOS疾病发生发展中的作用,可以为预防和治疗该疾病提供新的思路。


关键词: 脂肪组织,  棕色,  多囊卵巢综合征,  代谢,  综述 

[1] GOODMAN N F, COBIN R H, FUTTERWEIT W, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and Pcos Society Disease state clinical review:guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 2[J]. Endocr Pract,2015,21(12):1415-1426.
[2] LIM S S, NORMAN R J, DAVIES M J, et al. The effect of obesity on polycystic ovary syndrome:a systematic review and meta-analysis[J]. Obes Rev,2013,14(2):95-109.
[3] RODRÍGUEZ A, EZQUERRO S, MÉNDEZ-GIMÉNEZ L, et al. Revisiting the adipocyte:a model for integration of cytokine signaling in the regulation of energy metabolism[J]. Am J Physiol Endocrinol Metab,2015,309(8):E691-E714.
[4] GESTA S, TSENG Y H, KAHN C R. Developmental origin of fat:tracking obesity to its source[J]. Cell,2007,131(2):242-256.
[5] YUAN X, HU T, ZHAO H, et al. Brown adipose tissue transplantation ameliorates polycystic ovary syndrome[J]. Proc Natl Acad Sci U S A,2016,113(10):2708-2713.
[6] HOLMES D. PCOS:Benefits of brown adipose tissue transplantation[J]. Nat Rev Endocrinol,2016,12(6):312.
[7] SEALE P, BJORK B, YANG W, et al. PRDM16 controls a brown fat/skeletal muscle switch[J]. Nature,2008,454(7207):961-967.
[8] UIDRY M, YANG W, ST-PIERRE J, et al. Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and fat differentiation[J]. Cell Metab,2006,3(5):333-341.
[9] CYPESS A M, LEHMAN S, WILLIAMS G, et al. Identification and importance of brown adipose tissue in adult humans[J]. N Engl J Med,2009,360(15):1509-1517.
[10] COHADE C, OSMAN M, PANNU H K, et al. Uptake in supraclavicular area fat ("USA-Fat"):description on 18F-FDG PET/CT[J]. J Nucl Med,2003,44(2):170-176.
[11] CRISAN M, CASTEILLA L, LEHR L, et al. A reservoir of brown adipocyte progenitors in human skeletal muscle[J]. Stem Cells,2008,26(9):2425-2433.
[12] WU J, COHEN P, SPIEGELMAN B M. Adaptive thermogenesis in adipocytes:is beige the new brown?[J]. Genes Dev,2013,27(3):234-250.
[13] HUANG Y C, HSU C C, WANG P W, et al. Review analysis of the association between the prevalence of activated brown adipose tissue and outdoor temperature[J/OL]. Sci World J,2012,2012:793039.
[14] ROSENWALD M, PERDIKARI A, RVLICKE T, et al. Bi-directional interconversion of brite and white adipocytes[J]. Nat Cell Biol,2013,15(6):659-667.
[15] HANY T F, GHAREHPAPAGH E, KAMEL E M, et al. Brown adipose tissue:a factor to consider in symmetrical tracer uptake in the neck and upper chest region[J]. Eur J Nucl Med Mol Imaging,2002,29(10):1393-1398.
[16] CHEN Y I, CYPESS A M, SASS C A, et al. Anatomical and functional assessment of brown adipose tissue by magnetic resonance imaging[J]. Obesity (Silver Spring),2012,20(7):1519-1526.
[17] TSENG Y H, CYPESS A M, KAHN C R. Cellular bioenergetics as a target for obesity therapy[J]. Nat Rev Drug Discov,2010,9(6):465-482.
[18] STANFORD K I, MIDDELBEEK R J, TOWNSEND K L, et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity[J]. J Clin Invest,2013,123(1):215-223.
[19] MATSUSHITA M, YONESHIRO T, AITA S, et al. Impact of brown adipose tissue on body fatness and glucose metabolism in healthy humans[J]. Int J Obes (Lond),2014,38(6):812-817.
[20] BARTELT A, BRUNS O T, REIMER R, et al. Brown adipose tissue activity controls triglyceride clearance[J]. Nat Med,2011,17(2):200-205.
[21] VERGNES L, CHIN R, YOUNG S G, et al. Heart-type fatty acid-binding protein is essential for efficient brown adipose tissue fatty acid oxidation and cold tolerance[J]. J Biol Chem,2011,286(1):380-390.
[22] VEGIOPOULOS A, MVLLER-DECKER K, STRZODA D, et al. Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes[J]. Science,2010,328(5982):1158-1161.
[23] RODRIGUEZ A M, MONJO M, ROCA P, et al. Opposite actions of testosterone and progesterone on UCP1 mRNA expression in cultured brown adipocytes[J]. Cell Mol Life Sci,2002,59:1714-1723.
[24] MCDONALD R B, HORWITZ B A. Brown adipose tissue thermogenesis during aging and senescence[J]. J Bioenerg Biomembr,1999,31(5):507-516.
[25] RODRIGUEZ-CUENCA S, MONJO M, FRONTERA M, et al. Sex steroid receptor expression profile in brown adipose tissue. Effects of hormonal status[J]. Cell Physiol Biochem,2007,20(6):877-886.
[26] NOHARA K, WARAICH R S, LIU S, et al. Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice[J]. Am J Physiol Endocrinol Metab,2013,304(12):E1321-1330.
[27] WANG G X, ZHAO X Y, LIN J D. The brown fat secretome:metabolic functions beyond thermogenesis[J]. Trends Endocrinol Metab,2015,26(5):231-237.
[28] GUNAWARDANA S C, PISTON D W. Reversal of type 1 diabetes in mice by brown adipose tissue transplant[J]. Diabetes,2012,61(3):674-682.
[29] STANFORD K I, MIDDELBEEK R J, TOWNSEND K L, et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity[J]. J Clin Invest,2013,123(1):215-223.
[30] ROSENBAUM D, HABER R S, DUNAIF A. Insulin resistance in polycystic ovary syndrome:decreased expression of GLUT-4 glucose transporters in adipocytes[J]. Am J Physiol,1993, 264(2 Pt 1):E197-202.
[31] ORAVA J, NUUTILA P, LIDELL M E, et al. Different metabolic responses of human brown adipose tissue to activation by cold and insulin[J]. Cell Metab,2011,14(2):272-279.
[32] BARBER T M, DIMITRIADIS G K, ANDREOU A, et al. Polycystic ovary syndrome:insight into pathogenesis and a common association with insulin resistance[J]. Clin Med (Lond),2016,16(3):262-266.
[33] BOSTRÖM P, WU J, JEDRYCHOWSKI M P, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis[J]. Nature,2012,481(7382):463-468.
[34] BOSTRÖM P A, FERNÁNDEZ-REAL J M, MANTZOROS C. Irisin in humans:recent advances and questions for future research[J]. Metabolism,2014,63(2):178-180.
[35] 李娟.C57BL/6J小鼠白色脂肪与棕色脂肪组织蛋白质组学研究[D].北京:北京协和医学院,2015. LI Juan. Proteomics research of brown and white adipose tissue fat in C57BL/6J mice[D]. Beijing:Peking Union Medical College,2015. (in Chinese)
[36] HARMS M, SEALE P. Brown and beige fat:development, function and therapeutic potential[J]. Nat Med,2013,19(10):1252-1263.

[1] XU Jingjing, TAN Yanbin, ZHANG Minming. Medical imaging in tumor precision medicine: opportunities and challenges[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 455-461.
[2] PAN Jingying, HE Mengye, KE Wei, HU Menglin, WANG Meifang, SHEN Peng. Advances on correlation of PET-CT findings with breast cancer molecular subtypes, treatment response and prognosis[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 473-480.
[3] YANG Rong, YAO Linpeng, ZHANG Siying, CHEN Feng. Rat endothelial progenitor cells labeled with Molday IONTM EverGreen and in vitro MRI study[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 481-486.
[4] ZHANG Siying, CHEN Feng. Research progress of CT/MRI parametric response map in precision evaluation of therapeutic response of cancer patients[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 468-472.
[5] PAN Yao, CHEN Jieyu, YU Risheng. Accurate imaging diagnosis and evaluation of pancreatic cancer[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 462-467.
[6] WANG Mengyan, ZHU Biao. Research progress on genes mutations related to sulfa drug resistance in Pneumocystis jirovecii[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 563-569.
[7] WANG Haifeng, CHEN Tiantian, WANG Yueyue, LI Yu, ZHANG Lingyu, DING Yongxing, CHEN Sulian, WANG Wenrui, YANG Qingling, CHEN Changjie. CXC chemokine receptor 4 regulates breast cancer cell cycle through S phase kinase associated protein 2[J]. Journal of ZheJiang University(Medical Science), 2017, 46(4): 357-363.
[8] LI Yu, WANG Yueyue, WANG Haifeng, ZHANG Lingyu, DING Yongxing, CHEN Sulian, YANG Qingling, CHEN Changjie. Effects of lncRNA RP11-770J1.3 and TMEM25 expression on paclitaxel resistance in human breast cancer cells[J]. Journal of ZheJiang University(Medical Science), 2017, 46(4): 364-370.
[9] LI Yandie, LU Meiping. Progress on the study of NLRP3 inflammasome in autoinflammatory diseases of children[J]. Journal of ZheJiang University(Medical Science), 2017, 46(4): 449-453.
[10] HONG Fang, HUANG Xinwen, ZHANG Yu, YANG Jianbin, TONG Fan, MAO Huaqing, HUANG Xiaolei, ZHOU Xuelian, YANG Rulai, ZHAO Zhengyan. Screening for newborn organic aciduria in Zhejiang province:prevalence, outcome and follow-up[J]. Journal of ZheJiang University(Medical Science), 2017, 46(3): 240-247.
[11] ZHENG Jing, ZHANG Yu, HONG Fang, YANG Jianbin, TONG Fan, MAO Huaqing, HUANG Xiaolei, ZHOU Xuelian, YANG Rulai, ZHAO Zhengyan, HUANG Xinwen. Screening for fatty acid oxidation disorders of newborns in Zhejiang province:prevalence, outcome and follow-up[J]. Journal of ZheJiang University(Medical Science), 2017, 46(3): 248-255.
[12] WANG Liya, QIAN Yeqing, JIN Fan. Research progress on the safety of offsprings conceived by assisted reproductive technology[J]. Journal of ZheJiang University(Medical Science), 2017, 46(3): 279-284.
[13] YAN Kai, JIN Fan. Advances on prenatal diagnosis of birth defects associated with genetic disorders[J]. Journal of ZheJiang University(Medical Science), 2017, 46(3): 227-232.
[14] TANG Minyue, ZHU Yimin. The involvement of galectin-1 in implantation and pregnancy maintenance at the maternal-fetal interface[J]. Journal of ZheJiang University(Medical Science), 2017, 46(3): 321-327.
[15] HUANG Xinwen, ZHANG Yu, HONG Fang, ZHENG Jing, YANG Jianbin, TONG Fan, MAO Huaqing, HUANG Xiaolei, ZHOU Xuelian, YANG Rulai, ZHAO Zhengyan. Screening for amino acid metabolic disorders of newborns in Zhejiang province:prevalence, outcome and follow-up[J]. Journal of ZheJiang University(Medical Science), 2017, 46(3): 233-239.